Nasolacrimal drainage obstruction after radioiodine therapy: Case report and a review of the literature

Clinical Nuclear Medicine

Volumn 30, Issue 8, 2005, Pages 543-545

  Brockmann, Holger ^a   Wilhelm, Kai ^a   Joe, Alexius ^a   Palmedo, Holger ^a   Biersack, Hans Juergen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Epiphora; I 131; Nasolacrimal drainage system; Radioiodine therapy; Thyroid carcinoma

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; CASE REPORT; DACRYOCYSTOGRAPHY; DRUG MEGADOSE; EPIPHORA; FEMALE; HUMAN; LACRIMAL DUCT OCCLUSION; LUNG METASTASIS; RADIOISOTOPE THERAPY; REVIEW; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

CARCINOMA, PAPILLARY; DACRYOCYSTORHINOSTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LACRIMAL DUCT OBSTRUCTION; MIDDLE AGED; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; WHOLE-BODY COUNTING;

EID: 22644435606     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000170013.84378.2a     Document Type: Review

References (13)

1. Solans R, Bosch JA, Galofré P, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42:738-743.
2. Alexander C, Bader JB, Schaefer A, et al. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med. 1998;39:1551-1554.
3. Zetting G, Hanselmayer G, Fueger BJ, et al. Long-term impairment of lacrimal glands after radioiodine therapy: a cross-sectional study. Eur J Nucl Med. 2002;29:1428-1432.
4. Kloos RT, Duvuuri V, Jhiang SM, et al. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab. 2002;87:5817-5820.
5. Bums JA, Morgenstern KE, Cahill KV, et al. Nasolacrimal obstruction secondary to 1-131 therapy. Ophthalmol Plast Reconstr Surg. 2004;20:126-129.
6. Bakheet SM, Hammami MM. False-positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology. Clin Nucl Med. 1994;19:325-329.
7. Shepler TR, Sherman SI, Faustina MM, et al. Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma. Ophthalmol Plast Reconstr Surg. 2003;19:479-481.
8. Bartley GB. Acquired lacrimal drainage obstruction: an etiologic classification system, case reports, and a review of the literature. Part 1. Ophthalmol Plast Reconstr Surg. 1992;8:237-242.
9. Bartley GB. Acquired lacrimal drainage obstruction: an etiologic classification system, case reports, and a review of the literature. Part 2. Ophthalmol Plast Reconstr Surg. 1992;8:243-249.
10. Linberg JV, McCormick SA. Primary acquired nasolacrimal duct obstruction: a clinicopathologic report and biopsy technique. Ophthalmology. 1986;93:1055-1063.
11. Spitzweg C, Joba W, Schriever K, et al. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab. 1999;84:4178-4184.
12. Bakheet SM, Hammami MM, Hemidan A, et al. Radioiodine secretion in tears. J Nucl Med. 1998;39:1452-1454.
13. Zettinig G, Karanikas G, Hanselmayer G, et al. Radioactive contamination of contact lenses during radioiodine therapy. Nucl Med Commun. 2000;21:955-957.